Drug Profile
AUS 131/doxycycline
Alternative Names: Doxycycline/AUS-131; Doxycycline/s-equol; S-equol/doxycyclineLatest Information Update: 22 Sep 2015
Price :
$50
*
At a glance
- Originator Nexgen Dermatologics
- Class
- Mechanism of Action Estrogen receptor beta agonists; Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acne vulgaris
Most Recent Events
- 22 Sep 2015 No recent reports on development identified - Phase-I/II for Acne vulgaris in USA (PO)
- 30 Nov 2010 Phase-I/II clinical trials in Acne vulgaris in USA (PO)